Late Relapse of Diabetes After Bariatric Surgery: Not Rare, but Not a Failure
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To characterize the status of cardiometabolic risk factors after late relapse of type 2 diabetes mellitus (T2DM) and to identify factors predicting relapse after initial diabetes remission following bariatric surgery to construct prediction models for clinical practice. RESEARCH DESIGN AND METHODS: Outcomes of 736 patients with T2DM who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at an academic center (2004–2012) and had ≥5 years’ glycemic follow-up were assessed. Of 736 patients, 425 (58%) experienced diabetes remission (HbA1c <6.5% [48 mmol/mol] with patients off medications) in the 1st year after surgery. These 425 patients were followed for a median of 8 years (range 5–14) to characterize late relapse of diabetes. RESULTS: In 136 (32%) patients who experienced late relapse, a statistically significant improvement in glycemic control, number of diabetes medications including insulin use, blood pressure, and lipid profile was still observed at long-term. Independent baseline predictors of late relapse were preoperative number of diabetes medications, duration of T2DM before surgery, and SG versus RYGB. Furthermore, patients who relapsed lost less weight during the 1st year after surgery and regained more weight afterward. Prediction models were constructed and externally validated. CONCLUSIONS: While late relapse of T2DM is a real phenomenon (one-third of our cohort), it should not be considered a failure, as the trajectory of the disease and its related cardiometabolic risk factors is changed favorably after bariatric surgery. Earlier surgical intervention, RYGB (compared with SG) and more weight loss (less late weight regain) are associated with less diabetes relapse in the long-term.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, patients may only experience partial remission of comorbidities; e.g., a large number of patients who experience complete T2D remission in the early period after surgery suffer a relapse on long-term follow-up [4].”
Citations
Cites
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934 · cited 1×
“not at this target 5 years after surgery (9).”
BackgroundSelf-citationSjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundMingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundIFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3450-2 · Cited by 1,032 · cited 1×
“95% of the primary bariatric procedures worldwide in patients with T2DM (33,34) means that the findings of this study will be relevant to the practice of most of the bariatric surgeons globally.”
BackgroundHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003 · cited 4×
“© 2020 by the American Diabetes Association.”
MethodInfluentialSalminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946 · cited 1×
“1) Hospital Cĺınic de Barcelona, 2) patients with T2DM who were enrolled in the Sleeve vs Bypass (SLEEVEPASS) randomized clinical trial (16) from Finland, and 3) patients from Geisinger Clinic in Danville, PA.”
MethodSelf-citationStandardized outcomes reporting in metabolic and bariatric surgery
Brethauer, S. A., Kim, J., el Chaar, M., Papasavas, P., Eisenberg, D., Rogers, A., Ballem, N., Kligman, M., & Kothari, S. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.003 · Cited by 944
Self-citationBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552
Self-citationAminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E. (2019) · JAMA · doi:10.1001/jama.2019.14231 · Cited by 505
Self-citation
Cited by
Salminen, P., Grönroos, S., Helmiö, M., Hurme, S., Juuti, A., Juusela, R., Peromaa-Haavisto, P., Leivonen, M., Nuutila, P., & Ovaska, J. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.2229 · Cited by 456
Self-citationObesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
Sarma, S., Sockalingam, S., & Dash, S. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14290 · Cited by 435
“It can cause long-term remission of T2D in ~30% of patients, with the majority of patients experiencing improved glycaemia.(51)”
BackgroundBlüher, M. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16263 · Cited by 175
Lautenbach, A., Wernecke, M., Huber, T. B., Stoll, F., Wagner, J., Meyhöfer, S. M., Meyhöfer, S., & Aberle, J. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06211-9 · Cited by 92
Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes
Castellana, M., Procino, F., Biacchi, E., Zupo, R., Lampignano, L., Castellana, F., Sardone, R., Palermo, A., Cesareo, R., Trimboli, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa737 · Cited by 74
Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
Khafagy, R., & Dash, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.768119 · Cited by 60
Aminian, A., Kashyap, S. R., Wolski, K. E., Brethauer, S. A., Kirwan, J. P., Nissen, S. E., Bhatt, D. L., & Schauer, P. R. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005003 · Cited by 50
“In a large study with a median follow-up time of 8 years (range 5–14 years), in the 425 patients who experienced initial remission of T2DM within the first year after RYGB or SG, about one-third experienced late relapse of their diabetes.(23) For our study, reexamining PROs after a longer follow-up time (eg, 10-year d…”
BackgroundSelf-citationRemission of type 2 diabetes: always more questions, but enough answers for action
Rothberg, A. E., Lean, M. E. J., & Laferrère, B. (2024) · Diabetologia · doi:10.1007/s00125-023-06069-1 · Cited by 57
“While type 2 diabetes relapse after gastric bypass surgery is associated with weight regain, the best predictor of relapse is poor presurgical beta cell function [25–27].”
BackgroundDebédat, J., Roy, T. L., Voland, L., Belda, E., Alili, R., Adriouch, S., Lassen, P. B., Kasahara, K., Hutchison, E. R., Genser, L., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2050635 · Cited by 51
“HbA1C and fasting blood glucose values in the absence of glucose-lowering agents,(9) concerns 50% to 60% of patients after bariatric surgery, although the prevalence of DR lessens with time.(10,11) Several clinical parameters are associated with these differences in clinical outcomes, such as T2D duration, post-operat…”
BackgroundMetabolic surgery: A clinical update
Wilson, R. L., Aminian, A., & Tahrani, A. A. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14235 · Cited by 45
“remission after RYGB or SG reported that 32% experienced relapse of T2D at a median of 8 years follow-up.(50) However, the overall”
BackgroundSelf-citationDing, Y., Xu, T., Mao, G., Chen, Y., Qiu, X., Yang, L., Zhao, T. K., Xu, X., Feng, W., & Wu, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112003 · Cited by 42
MacKay, D., Chan, C. B., Dasgupta, K., Dominy, C., Gagner, M., Jin, S., Kim, J., Little, J. P., MacDonald, B., McInnes, N., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.10.004 · Cited by 46
“However, follow-up studies suggest that at least 35% to 50% of the individuals who initially achieve remission of diabetes may eventually experience relapse (22,23).”
BackgroundInfluentialPredictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study
Moriconi, D., Manca, M. L., Anselmino, M., Rebelos, E., Bellini, R., Taddei, S., Ferrannini, E., & Nannipieri, M. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101282 · Cited by 40
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes Care · doi:10.2337/dci21-0051 · Cited by 39
Ghusn, W., Ikemiya, K., Annan, K. A., Acosta, A. J., Dayyeh, B. K. A., Lee, E. W., Spaniolas, K., Kendrick, M. L., Higa, K. D., Ma, P., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06622-2 · Cited by 36
“More importantly, many patients experience late relapse of their T2DM after bariatric surgery [14]; several patient-specific factors have been associated with relapse, including preoperative glycosylated hemoglobin (HbA1c), T2DM duration, and T2DM medication usage (e.”
BackgroundType 2 Diabetes Remission 5 Years After Laparoscopic Sleeve Gastrectomy: Multicenter Cohort Study
Mizera, M., Wysocki, M., Bartosiak, K., Franczak, P., Hady, H. R., Kalinowski, P., Myśliwiec, P., Orłowski, M., Paluszkiewicz, R., Piecuch, J., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05088-w · Cited by 35
COVID-19 and Obesity—the Management of Pre- and Post-bariatric Patients Amidst the COVID-19 Pandemic
Yeo, C., Ahmed, S., Oo, A. M., Koura, A. N., Sanghvi, K., & Yeo, D. X. W. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04670-6 · Cited by 30
“In the long run, concerns of DM relapse [18] , inadequate weight loss, or weight regain also need to be addressed [19] .”
BackgroundNie, Y., Zhang, Y., Liu, B., & Meng, H. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07733-8 · Cited by 30
“These issues suggest a potential suboptimal clinical response after the initial surgery, exposing patients to the heightened risks associated with revision [5, 9–13].”
Success (but Unfinished) Story of Metabolic Surgery
Aminian, A., & Nissen, S. E. (2020) · Diabetes Care · doi:10.2337/dci20-0006 · Cited by 28
Self-citationJans, A., Szabó, É., Näslund, I., Ottosson, J., Näslund, E. B., & Stenberg, E. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.12.005 · Cited by 29
Pharmacotherapy before and after bariatric surgery
Alabduljabbar, K. A., & le Roux, C. W. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155692 · Cited by 30
Diabetes Remission After Bariatric Surgery: A 10-Year Follow-Up Study
Meira, I., Menino, J., Ferreira, P., Leite, A. R., Gonçalves, J., Ferreira, H. U., Ribeiro, S., Moreno, T., Silva, D. F., Pedro, J. M. P., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07592-9 · Cited by 31
Stenberg, E., Olbers, T., Cao, Y., Sundbom, M., Jans, A., Ottosson, J., Näslund, E. B., & Näslund, I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002033 · Cited by 25
Metabolic and cardiovascular outcomes of bariatric surgery
Iqbal, Z., Adam, S., Ho, J. H., Syed, A. A., Ammori, B. J., Malik, R. A., & Soran, H. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000696 · Cited by 28
“[34] found that despite recurrence, patients still ha BPD, bilopancreatic diversion; LAGB, laparoscopic gastric band; RYGB, Roux-en-Y g”
BackgroundInsulin resistance in bariatric surgery
Stenberg, E., & Thorell, A. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000657 · Cited by 26
Yu, Z., Li, P., Li, P., Zhang, H., & Zhang, Y. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05692-4 · Cited by 26
Kanai, R., Kinoshita, S., Kanbe, I., Sameda, M., Yamaoka, S., Horikawa, O., Watanabe, Y., Tatsuno, I., Shirai, K., Oshiro, T., et al. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2023.100098 · Cited by 31
“…achieve 30 % weight reduction and high remission rate of type 2 diabetes [22], studies have shown that some patients have relapse of type 2 diabetes due to postoperative weight recurrence [7,23 – 25], and some have poor metabolic improvement due to inadequate postoperative weight reduction [6,26].”
BackgroundBariatric Surgery: Targeting pancreatic β cells to treat type II diabetes
Liu, T., Zou, X., Ruze, R., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1031610 · Cited by 25
Hage, K., Ikemiya, K., Ghusn, W., Lu, L. Y., Kennel, K. A., McKenzie, T. J., Kellogg, T. A., Dayyeh, B. K. A., Higa, K. D., Spaniolas, K., et al. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.09.025 · Cited by 27
Cardiovascular risk reduction following metabolic and bariatric surgery.
Albaugh, V. L., Kindel, T. L., Nissen, S. E., & Aminian, A. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2020.12.012 · Cited by 21
Self-citationSjöholm, K., Svensson, P., Taube, M., Jacobson, P., Andersson‐Assarsson, J. C., Carlsson, L. M. S., & Peltonen, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04763-2 · Cited by 27
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes · doi:10.2337/db21-0777 · Cited by 22
Elhag, W., Lock, M., & Ansari, W. E. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06528-z · Cited by 26
Remission of Type 2 Diabetes: User’s Guide
Jin, S., BAJAJ, H. S., Brazeau, A., Champagne, J., MacDonald, B., MacKay, D., Reichert, S. M., Vallis, M., BAJAJ, H. S., Gilbert, J. D., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.10.005 · Cited by 24
Examining the evidence for weight management in individuals with type 2 diabetes
Garvey, W. T., Umpierrez, G. E., Dunn, J. P., Kwan, A. Y. M., Varnado, O. J., Konig, M., & Levine, J. A. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14764 · Cited by 18
Bruno, J., Walker, J. M., Nasserifar, S., Upadhyay, D., Ronning, A., Vanegas, S. M., Popp, C. J., Barua, S., & Alemán, J. O. (2024) · iScience · doi:10.1016/j.isci.2024.111501 · Cited by 17
Nudotor, R. D., Prokopowicz, G. P., Abbey, E. J., Gonzalez, A., Canner, J. K., & Steele, K. E. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2020.12.024 · Cited by 15
Alqunai, M. S., & Alrashid, F. F. (2022) · PubMed · Cited by 22
Hage, K., Ma, P., Ghusn, W., Ikemiya, K., Acosta, A. J., Vierkant, R. A., Dayyeh, B. K. A., Higa, K. D., & Ghanem, O. M. (2024) · Surgical Innovation · doi:10.1177/15533506241229040 · Cited by 15
“22 The underlying mechanisms by which patients achieve T2DM remission after bariatric surgery are still not fully understood.”
BackgroundBariatric surgery and diabetes: Current challenges and perspectives
He, Y., Hu, X.-D., Liu, J., Li, H., & Lu, S.-F. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i8.1692 · Cited by 13
Kwon, Y., Kwon, J., Kim, D., Ha, J., Park, S., Hwang, J., Heo, Y., & Park, S. S. (2021) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2021.03.019 · Cited by 13
Watanabe, Y., Yamaguchi, T., Nagayama, D., Tanaka, S., Sasaki, A., Naitoh, T., Matsubara, H., Yokote, K., Okazumi, S., Ugi, S., et al. (2023) · Obesity Facts · doi:10.1159/000529546 · Cited by 13
Predictors of diabetes relapse after metabolic surgery in Asia
Yang, P., Su, Y., Shen, S., Lee, P., Lin, M., Lee, W., & Wang, W. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.11.018 · Cited by 10
Saarinen, I., Grönroos, S., Hurme, S. A. M., Peterli, R., Helmiö, M., Bueter, M., Strandberg, M., Wölnerhanssen, B. K., & Salminen, P. T. P. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.10.036 · Cited by 10
Self-citationMiller-Matero, L. R., Haley, E. N., Loree, A. M., Braciszewski, J. M., Maye, M. P., Sehgal, M., & Carlin, A. M. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.09.027 · Cited by 12
Nguyen, A., Khafagy, R. T. M., Hashemy, H., Kuo, K. H. M., Roshandel, D., Paterson, A. D., & Dash, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1146099 · Cited by 9
Osteoarthritis in patients with obesity: The bariatric surgery impacts on its evolution
Eymard, F., & Aron‐Wisnewsky, J. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105639 · Cited by 11
Sadeghi, S., Hosseinpanah, F., Khalaj, A., Ebadinejad, A., Mahdavi, M., Valizadeh, M., & Barzin, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15974 · Cited by 12
“16,28,35 reported that gastric bypass was associated with a significantly lower rate of relapse compared to SG. Additionally, Jans et al. 16 suggested that SG may be linked to an increased risk of relapse compared to RYGB.”
Gobbo, G. D. D., Mahmoud, N., Barajas-Gamboa, J. S., Klingler, M. J., Barrios, P. A., Abril, C. M., Raza, J., Aminian, A., Rosenthal, R. J., Corcelles, R., et al. (2022) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2021.0096 · Cited by 10
Self-citationLupoli, R., Lembo, E., Giosuè, A., Schiavo, L., & Capaldo, B. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.02.019 · Cited by 10
Ferreira, I., Machado de Oliveira, R., Carvalho, A. S., Teshima, A., Beck, H. C., Matthiesen, R., Costa-Silva, B., & Macedo, M. P. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00353 · Cited by 9
Zhang, N., Zhou, B., Wang, H., Xue, X., Huang, Y., Wang, S., Wang, Z., Niu, W., Liu, B., Nie, Y., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112164 · Cited by 9
The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus Remission: A Systematic Review
Mohamed, A. M., Aljabal, H., Al-Alawi, A. S., & Al-Nooh, N. (2024) · Cureus · doi:10.7759/cureus.74755 · Cited by 12
Stenberg, E., Cao, Y., Jernberg, T., & Näslund, E. B. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.04.005 · Cited by 9
Ortega, P., Yao, R., & Izzi‐Engbeaya, C. N. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003229 · Cited by 7
“However, it has been demonstrated that patients with longstanding T2DM may experience lower remissions rates and later disease relapse [ 52 , 53 ] .”
Accuracy of prediction models for long-term type 2 diabetes remission after gastric bypass
Cardoso, S., Pereira, S. S., de Almeida, R. F., Osório, C., Silva, D., Nora, M. C., Monteiro, M. P., & Guimarães, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02092-1 · Cited by 10
“Similar relapse rates were observed by other authors [26].”
ResultCardiorenal outcomes in eligible patients referred for bariatric surgery
Dash, S., Everett, K., Jackson, T. D., Okrainec, A., Urbach, D. R., Sockalingam, S., Shah, B. R., & Farkouh, M. E. (2021) · Obesity · doi:10.1002/oby.23294 · Cited by 7
“Bariatric surgery is the most efficacious treatment for sustained weight loss and improves/remits a number of CVD risk factors, including T2D, hypertension, sleep apnea, and dyslipidemia (6,7,26).”
Lee, J. H., Jaung, R., Beban, G. R., Evennett, N. J., & Cundy, T. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001837 · Cited by 7
Arrowaili, A. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07856-y · Cited by 7
“Consequently, patients may experience only partial remission of associated medical problems; for instance, many patients who achieve complete remission of type 2 diabetes shortly after surgery may relapse during long-term follow-up [6].”
Metabolic Surgery: Paradigm Shift in Metabolic Syndrome/Diabetes Therapy
Rühle, A., Billeter, A. T., & Müller-Stich, B. P. (2022) · Visceral Medicine · doi:10.1159/000521707 · Cited by 6
Andersson, D. P., Tseng, B. T. P., Arner, P., & Dahlman, I. A. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.02.013 · Cited by 7
Surgical treatment for obesity
Lee, D. Y., & Lee, C. M. (2022) · Journal of Korean Medical Association · doi:10.5124/jkma.2022.65.7.417 · Cited by 6
Selecting surgical procedures for medically uncontrolled type 2 diabetes
COHEN, R. V. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.03.009 · Cited by 6
Akkuş, G., & Tetıker, T. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1312 · Cited by 6
Strategies to Maintain the Remission of Diabetes Following Metabolic Surgery
Kim, M. K., & Kim, H. S. (2023) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2023.12.2.26 · Cited by 5
“In addition, patients who lose significantly less weight during the first year following surgery are more likely to experience relapse [13,16].”
BackgroundInfluentialZhong, M., Li, Y., Cheng, Y., Liu, Q.-R., Hu, S., & Zhang, G. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.453 · Cited by 5
Wen, W., Huang, H., Lin, H.-C., Lo, W., Chen, S., & Lee, M. (2022) · Nutrients · doi:10.3390/nu14020320 · Cited by 5
“Nevertheless, extended research found that T2DM relapsed after years followup [5,6].”
BackgroundKheniser, K. G., Aminian, A., & Kashyap, S. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01350-8 · Cited by 5
Self-citationCOHEN, R. V., Kermansaravi, M., Levinson, R. S., Lakdawala, M. A., Parmar, C. D., Seki, Y., Prager, G., Salminen, P. T. P., Gastrectomy, M. O. T. G. C. R. F. O. O. A. S., Ackerman, M., et al. (2025) · British journal of surgery · doi:10.1093/bjs/znaf188 · Cited by 4
Self-citationCali, M., Ernest, D. K., Xie, L., Schellinger, J. N., Mathew, M. S., Chandrasekhar, A., Guo, J., Vega, G. L., Messiah, S. E., & Almandoz, J. P. (2025) · Clinical Obesity · doi:10.1111/cob.12735 · Cited by 4
Pané, A., Viaplana, J., Giró, O., Llopis, J., Ibarzábal, A., de Hollanda, A., Vidal, J., Ortega, E., Jiménez, A., & Chiva‐Blanch, G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad473 · Cited by 4
Self-citationElhag, W., Elgenaied, I., Lock, M., & Ansari, W. E. (2025) · Obesity Surgery · doi:10.1007/s11695-024-07664-w · Cited by 3
“Despite relapse, studies have shown that such patients still displayed significant improvements in their metabolic profile, comparable to those of patients with long-term remission, suggesting that T2DM relapse years after SG should not be considered a failure [4, 34].”
Fonseca, H., & de Oliveira, J. J. F. (2020) · Obesity · doi:10.1002/oby.23020 · Cited by 3
“who undergo BS have post-BS diabetes relapse, and these are the ones who regain more weight (6).”
BackgroundCombined medical strategies for the management of type 2 diabetes mellitus and obesity in adults
Tarazi, M. S., Touhamy, S., Tchang, B. G., & Shukla, A. P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1942841 · Cited by 4
Cao, Y., Luo, P., Tang, H., Li, P., Wang, G., Li, W., Song, Z. J., Su, Z., Sun, X., Yi, X., et al. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.08.004 · Cited by 5
Diabetic Markers, Five Years after Bariatric Surgery
Behrooznia, Z., Jangjoo, A., Seraj, F. Q. M., Khadem‐Rezaiyan, M., Zandbaf, T., & Hassani, S. (2023) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2023.357 · Cited by 3
“23 It should also be noted that following bariatric surgery, the relapse period increases in long-term observation, especially in RYGB.”
BackgroundCefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., Rosenblum, N. D., Rosenblum, N. D., Cefalu, W. T., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.09.126 · Cited by 10
López‐de‐Andrés, A., Jiménez‐García, R., Cuadrado‐Corrales, N., Carabantes-Alarcón, D., Hernández‐Barrera, V., de Miguel‐Díez, J., Jiménez-Sierra, A., & Zamorano‐León, J. J. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004351 · Cited by 2
“Several epidemiological studies have indicated that RYGB was more likely to be performed than SG in patients with T2DM, 10 22 possibly because RYGB seems to achieve a greater reduction in weight and for longer time in patients with T2DM than SG. 7 23 24 A follow-up study of patients with T2DM in the USA comparing diff…”
InfluentialGreater durability of weight loss at ten years with gastric bypass compared to sleeve gastrectomy
Tan, S. Y. T., Lee, Y. Q., Syn, G., Tseng, F. S., Chua, J. K. L., Tan, H. C., Ho, E. T. L., Kovalik, J. P., Lim, C. H., Eng, A. K. H., et al. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01760-2 · Cited by 3
Mirghani, H. O. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i11.109426 · Cited by 4
“The discrepancy in results could be explained by the differences in baseline HbA1c, BMI, and duration of diabetes mellitus[67,68].”
Steffen, R., & Horber, F. (2021) · Annals of Surgery Open · doi:10.1097/as9.0000000000000053 · Cited by 2
Kırkıl, C., Yur, M., Aydın, İ., Bozdağ, A., Aslan, A., & Ebiloğlu, M. F. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07906-5 · Cited by 2
“Unfortunately, one-third of patients with initial remission later suffer from relapse [6, 7].”
Aminian, A. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.03.027 · Cited by 2
Self-citationYang, J., Zhang, C.-Z., Wang, J., & Zhang, J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.103567 · Cited by 1
The effect of weight change on death and cardiovascular events after Roux-en-Y gastric bypass
Stenberg, E., Näslund, E. B., Cao, Y., Ottosson, J., & Näslund, I. (2025) · British journal of surgery · doi:10.1093/bjs/znaf170 · Cited by 1
“Recurrent weight gain has been reported to have negative effects on metabolic biomarkers and be associated with an increased risk for relapse of metabolic co-morbidities 22,23 .”
Kapralou, A. N., Yapijakis, C., & Chrousos, G. P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080657 · Cited by 1
Choi, J., Park, S. S., & Kwon, Y. (2025) · Gastric Cancer · doi:10.1007/s10120-025-01673-z · Cited by 1
Phan, A., Hirlemann, M., Ilchmann-Diounou, H., Rives‐Lange, C., Czernichow, S., Greenfield, J. R., Gall, M. L., & Carette, C. (2025) · Obesity and Endocrinology · doi:10.1093/obendo/wjaf012 · Cited by 2
Leyaro, B. J., Howie, L., Ali, A., & Carragher, R. (2026) · Obesity Facts · doi:10.1159/000552002 · Cited by 1
“Studies suggest that the short-term bariatric surgery can lead to T2DM remission in approximately 60%–95% of patients [3, 4].”
InfluentialBoutros, T., Ghusn, W., Klim, J., Ghazal, N. E., Acra, A., Laplante, S. J., & Ghanem, O. M. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08837-5 · Cited by 1
“The superiority of bypass procedures for T2D outcomes is well established, with previous studies demonstrating that RYGB was associated with less T2D recurrence over time compared with SG [11].”
Zubiaga, L., & Ruíz-Tóvar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822922-4.00001-6 · Cited by 1
Nasta, A. M., Goel, R., Goel, M., & Malek, A. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05570-z · Cited by 1
Tighten Your Belt! Banded Roux-en-Y Gastric Bypass for Diabetes Remission?
Egan, A. M., & Vella, A. V. (2022) · Diabetes Care · doi:10.2337/dci22-0015 · Cited by 1
Waataja, J. J., Ikramuddin, S., Gal, D., & Billington, C. J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002713 · Cited by 1
Rocha, R. M. S., de Souza, M. F. C., Costa, D. V., Pereira, L. M. C., Costa, J. O., Nascimento, R. D. J., Rabelo, A. F. D. A., dos Santos-Junior, A. M., Filho, M. F. D. D. S., Morais, A. L. D. J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78792-7 · Cited by 2
“Lower percentages of weight loss and higher rates of weight regain after surgery have been associated with disease recurrence 43,48 .”
Recurrent Diabetes Following Bariatric Surgery: Incidence and Management
Chen, J., & Brethauer, S. A. (2020) · Current Surgery Reports · doi:10.1007/s40137-020-00268-0 · Cited by 1
Self-citationImpact of Excessive Weight Loss on Cardiovascular Risk After Two Years of Bariatric SurgeryPreprint
Pedron, F. F., Alvarez, G. D. C., Patias, L. D., Machado, A. C. D. A., de Lima, L. O., de Moura, D. S., Calcing, A., & de Moraes, C. M. B. (2021) · Research Square · doi:10.21203/rs.3.rs-350367/v1 · Cited by 1
Bariatric Procedure Selection in Diabetics
Stroud, A., & Stucke, R. S. (2020) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-030-55329-6_5 · Cited by 1
Chua, M. W. J. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05596-3
Résultats de la chirurgie bariatrique sur le diabète
Halimi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-76753-1.00104-1
Metadata
- Authors
- Aminian, A., Vidal, J., Salminen, P., Still, C. D., Nor Hanipah, Z., Sharma, G., Tu, C., Wood, G. C., Ibarzabal, A., Jimenez, A., Brethauer, S. A., Schauer, P. R., & Mahawar, K.
- Affiliations
- Cleveland Clinic (US)
- Obesity Unit, Hospital Clínic de Barcelona, Barcelona, Spain
- University of Turku (FI)
- Geisinger Medical Center (US)
- Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, OH
- Pennington Biomedical Research Center (US)
- Sunderland Royal Hospital (GB)
- Corresponding author
- Aminian, Ali
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-01-23
- Volume
- 43
- Issue
- 3
- Pages
- 534-540
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3001053202
- Cited by
- 122
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 21 · 2021: 28 · 2020: 14
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- green
- psasir.upm.edu.my
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, bariatric surgery, late recurrence, diabetes remission, Roux-en-Y gastric bypass, sleeve gastrectomy, weight regain, cardiometabolic risk factors, predictors of relapse, prediction model, insulin use, long-term outcomes
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gastrectomy, Humans, Male, Middle Aged, Prognosis, Recurrence, Retrospective Studies, Time Factors, Gastric Bypass, Weight Loss, Incidence, Treatment Failure, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.